Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

Completed

• Conditions: Prostate Cancer
• Interventions: Radiation: MVCT

• Registration Number: NCT01810627
• Lead Sponsor: William St Clair

Brief Summary

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-03-11
• Study First Submitted QC: 2013-03-11
• Study First Posted: 2013-03-13
• Study Start: 2013-09
• Primary Completion: 2016-04
• Study Completion: 2016-04
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-22
• Last Update Posted: 2017-09-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
MVCT	MVCT	Patients will receive an additional MVCT scan at their one month follow up visit.

Primary Outcome Measures

Name	Time	Method
Change in prostate volume measured in cm^3	One month post implant	Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.

Trial Locations

Locations (1)

Markey Cancer Center; 🇺🇸 Lexington, Kentucky, United States